Cargando…

Endoscopic duodenal stenting is efficient, but has higher rate of reoperations than gastrojejunostomy in palliative treatment for gastric outlet obstruction

BACKGROUND: Surgical gastrojejunostomy has traditionally been the palliative treatment of choice for patients with advanced malignancies and gastric outlet obstruction syndrome. Recently, palliative endoscopic duodenal stenting has increased in popularity. We report outcomes after gastrojejunostomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Laitamäki, Matti, Tyrväinen, Tuula, Lehto, Juho T., Laukkarinen, Johanna, Ukkonen, Mika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468122/
https://www.ncbi.nlm.nih.gov/pubmed/35648229
http://dx.doi.org/10.1007/s00423-022-02565-x
_version_ 1784788343362420736
author Laitamäki, Matti
Tyrväinen, Tuula
Lehto, Juho T.
Laukkarinen, Johanna
Ukkonen, Mika
author_facet Laitamäki, Matti
Tyrväinen, Tuula
Lehto, Juho T.
Laukkarinen, Johanna
Ukkonen, Mika
author_sort Laitamäki, Matti
collection PubMed
description BACKGROUND: Surgical gastrojejunostomy has traditionally been the palliative treatment of choice for patients with advanced malignancies and gastric outlet obstruction syndrome. Recently, palliative endoscopic duodenal stenting has increased in popularity. We report outcomes after gastrojejunostomy and duodenal stenting when used for palliative indications. METHODS: Consecutive patients undergoing palliative gastrojejunostomy or palliative endoscopic duodenal stenting in a Finnish tertiary referral center between January 2015 and December 2020 were included. The postoperative outcomes of these two palliative interventions were compared. The main outcome measures were mortality and morbidity, rate of reoperations, postoperative oral intake ability, and length of hospital stay. RESULTS: A total of 88 patients, 46 (52%) patients underwent palliative gastrojejunostomy and 42 (48%) duodenal stenting. All patients had malignant disease, most typically hepatopancreatic cancer. Nineteen (44%) patients in duodenal stenting group and 4 (8.7%) patients in gastrojejunostomy group required subsequent interventions due to persisting or progressing symptoms (p < 0.001). Median delay until first oral intake was 2 days (1–24) after gastrojejunostomy and 0 days (0–3) after stenting (p < 0.001). Postoperative morbidity was 30% after gastrojejunostomy and 45% after stenting (p < 0.001). Median length of hospital stay was 7 days (1–27) after surgery and 5 days (0–20) after endoscopy (p < 0.001). CONCLUSIONS: Patients undergoing endoscopic duodenal stenting are more able to initiate rapid oral intake and have shorter hospital stay. On the other hand, there are significantly more reoperations in stenting group. If the patient’s life expectancy is short, we recommend stenting, but for patients whose life expectancy is longer, gastrojejunostomy could be a better procedure, for the reasons mentioned above.
format Online
Article
Text
id pubmed-9468122
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94681222022-09-14 Endoscopic duodenal stenting is efficient, but has higher rate of reoperations than gastrojejunostomy in palliative treatment for gastric outlet obstruction Laitamäki, Matti Tyrväinen, Tuula Lehto, Juho T. Laukkarinen, Johanna Ukkonen, Mika Langenbecks Arch Surg Original Article BACKGROUND: Surgical gastrojejunostomy has traditionally been the palliative treatment of choice for patients with advanced malignancies and gastric outlet obstruction syndrome. Recently, palliative endoscopic duodenal stenting has increased in popularity. We report outcomes after gastrojejunostomy and duodenal stenting when used for palliative indications. METHODS: Consecutive patients undergoing palliative gastrojejunostomy or palliative endoscopic duodenal stenting in a Finnish tertiary referral center between January 2015 and December 2020 were included. The postoperative outcomes of these two palliative interventions were compared. The main outcome measures were mortality and morbidity, rate of reoperations, postoperative oral intake ability, and length of hospital stay. RESULTS: A total of 88 patients, 46 (52%) patients underwent palliative gastrojejunostomy and 42 (48%) duodenal stenting. All patients had malignant disease, most typically hepatopancreatic cancer. Nineteen (44%) patients in duodenal stenting group and 4 (8.7%) patients in gastrojejunostomy group required subsequent interventions due to persisting or progressing symptoms (p < 0.001). Median delay until first oral intake was 2 days (1–24) after gastrojejunostomy and 0 days (0–3) after stenting (p < 0.001). Postoperative morbidity was 30% after gastrojejunostomy and 45% after stenting (p < 0.001). Median length of hospital stay was 7 days (1–27) after surgery and 5 days (0–20) after endoscopy (p < 0.001). CONCLUSIONS: Patients undergoing endoscopic duodenal stenting are more able to initiate rapid oral intake and have shorter hospital stay. On the other hand, there are significantly more reoperations in stenting group. If the patient’s life expectancy is short, we recommend stenting, but for patients whose life expectancy is longer, gastrojejunostomy could be a better procedure, for the reasons mentioned above. Springer Berlin Heidelberg 2022-06-01 2022 /pmc/articles/PMC9468122/ /pubmed/35648229 http://dx.doi.org/10.1007/s00423-022-02565-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Laitamäki, Matti
Tyrväinen, Tuula
Lehto, Juho T.
Laukkarinen, Johanna
Ukkonen, Mika
Endoscopic duodenal stenting is efficient, but has higher rate of reoperations than gastrojejunostomy in palliative treatment for gastric outlet obstruction
title Endoscopic duodenal stenting is efficient, but has higher rate of reoperations than gastrojejunostomy in palliative treatment for gastric outlet obstruction
title_full Endoscopic duodenal stenting is efficient, but has higher rate of reoperations than gastrojejunostomy in palliative treatment for gastric outlet obstruction
title_fullStr Endoscopic duodenal stenting is efficient, but has higher rate of reoperations than gastrojejunostomy in palliative treatment for gastric outlet obstruction
title_full_unstemmed Endoscopic duodenal stenting is efficient, but has higher rate of reoperations than gastrojejunostomy in palliative treatment for gastric outlet obstruction
title_short Endoscopic duodenal stenting is efficient, but has higher rate of reoperations than gastrojejunostomy in palliative treatment for gastric outlet obstruction
title_sort endoscopic duodenal stenting is efficient, but has higher rate of reoperations than gastrojejunostomy in palliative treatment for gastric outlet obstruction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468122/
https://www.ncbi.nlm.nih.gov/pubmed/35648229
http://dx.doi.org/10.1007/s00423-022-02565-x
work_keys_str_mv AT laitamakimatti endoscopicduodenalstentingisefficientbuthashigherrateofreoperationsthangastrojejunostomyinpalliativetreatmentforgastricoutletobstruction
AT tyrvainentuula endoscopicduodenalstentingisefficientbuthashigherrateofreoperationsthangastrojejunostomyinpalliativetreatmentforgastricoutletobstruction
AT lehtojuhot endoscopicduodenalstentingisefficientbuthashigherrateofreoperationsthangastrojejunostomyinpalliativetreatmentforgastricoutletobstruction
AT laukkarinenjohanna endoscopicduodenalstentingisefficientbuthashigherrateofreoperationsthangastrojejunostomyinpalliativetreatmentforgastricoutletobstruction
AT ukkonenmika endoscopicduodenalstentingisefficientbuthashigherrateofreoperationsthangastrojejunostomyinpalliativetreatmentforgastricoutletobstruction